Blood in the street: Ardent and Sirtex price drops
Market legend and British noblemen, Baron Nathan Mayer Rothschild, eloquently described the contrarian investment thesis as: “buy when there is blood in the streets, even when the blood is your own.” History has been kind to Baron Rothschild’s theory and recently two Australian companies proved him right again. Shareholders were quick to savage the share prices of both Ardent Leisure Group (ASX: AAD) and Sirtex Medical Limited (ASX: SRX) after significant announcements in the past two weeks, providing exceptional contrarian investment opportunities. Geoff Wilson recently wrote an article looking more closely at these two scenarios, which you can view here: (VIEW LINK)
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Wilson Asset Management has a track record of making a difference for shareholders and the community for 25 years and is the investment manager for eight LICs - WAM Capital (ASX: WAM), WAM Leaders (ASX: WLE), WAM Global (ASX: WGB), WAM Microcap (ASX: WMI), WAM Alternative Assets (ASX: WMA), WAM Strategic Value (ASX: WAR), WAM Research (ASX: WAX) and WAM Active (ASX: WAA) - and the Wilson Asset Management Leaders Fund. Wilson Asset Management invests over $5 billion on behalf of more than 130,000 retail investors. Wilson Asset Management created and is the lead supporter of the first LICs to deliver both investment and social returns: Future Generation Australia (ASX: FGX) and Future Generation Global (ASX: FGG).
1 topic
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
This recently triggered market signal has never failed to predict gains
Ophir Asset Management